Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adamis, Aptinyx Aquestive, Bavarian Nordic, Celyad, Clarity, Cyclerion, Daewoong, Discgenics, Elpiscience, Evelo, Genmab, Goldfinch, Humacyte, Kazia, Lynk, Lyra, Medivir, Oncocross, PDS, Pliant, Pharmabcine, Seagen, Seelos, Takeda, TG, Transcenta, Zynerba.